James Armitage
Directeur/Membre du Conseil chez TESARO INC
Fortune : 87 418 $ au 31/05/2024
Profil
Dr. James O.
Armitage, MD, is an Independent Director at Cardiff Oncology, Inc. and a Professor-Internal Medicine at University of Nebraska Medical Center.
He is on the Board of Directors at Cardiff Oncology, Inc. and Tesaro, Inc. Dr. Armitage was previously employed as a President by American Society for Blood & Marrow Transplantation and a President & Director by American Society of Clinical Oncology, Inc. He also served on the board at MGI PHARMA, Inc. He received his undergraduate degree from the University of Nebraska and a doctorate degree from the University of Nebraska Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
0,06% | 22/04/2024 | 27 490 ( 0,06% ) | 87 418 $ | 31/05/2024 |
Postes actifs de James Armitage
| Sociétés | Poste | Début |
|---|---|---|
| TESARO INC | Directeur/Membre du Conseil | 09/05/2013 |
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/04/2020 |
| University of Nebraska Medical Center | Corporate Officer/Principal | 01/01/1982 |
Anciens postes connus de James Armitage
| Sociétés | Poste | Fin |
|---|---|---|
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Directeur/Membre du Conseil | 29/01/2008 |
| American Society for Blood & Marrow Transplantation | President | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | President | - |
Formation de James Armitage
| University of Nebraska Medical Center | Doctorate Degree |
| University of Nebraska | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
| American Society for Blood & Marrow Transplantation |
